Yahoo Web Search

Search results

    • Two Is Better Than One in the Alzheimer’s Market

      Two Is Better Than One in the Alzheimer’s Market

      The Wall Street Journal via Yahoo Finance· 13 hours ago

      Biogen and Eisai are very much at an early stage of building awareness of their drug while lobbying for less stringent reimbursement rules from the...